Fair Value Calculator Fair Value Calculator
EN DE

Global Bio-chem Technology Group (GBCMY) Fair Value & Analysis

Consumer Defensive · US · Market cap $139M

GB Global Bio-chem Technology Group logo Global Bio-chem Technology Group GBCMY · US
Price$4.14
Fair Value$1.77
Upside-57.3%
Quality42/100
Watch Global Bio-chem Technology Group for free, get notified when fair value or trend changes. Watch for free
Evidence: Medium Range $0.9350 – $2.30

Fair value as of: Jul 17, 2026

From 11 valuation models · updated today

Share price +900.0% over the past month.

Price vs Fair Value (12 months)

$4.14 $0.3226 Fair Value $1.77 Jul 2025 Jul 2026

12‑month range $0.3226 – $4.14 · fair‑value band $0.9350 – $2.30 · the $4.14 price screens above the $1.77 fair value. As of Jul 17, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Global Bio-chem Technology Group (GBCMY) currently trades at $4.14, while our model-based Fair Value estimate is $1.77, implying the stock looks roughly 57.3% overvalued today. We read business quality at 42/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Global Bio-chem Technology Group generated revenue of $2.3B at a net margin of 6.9%. Revenue declined 0.9% year over year. Net debt stands at $1.7B. The stock trades on a trailing P/E of 10.3. Fundamentals as of Jul 17, 2026

Our scenario range runs from $0.9350 (bear case) to $2.30 (bull case); at $4.14, the current price sits above that range. For context, the median of 10 Consumer Defensive peers we cover trades at -15% fair-value upside, at -57%, GBCMY screens richer than that median.

Key figures & financial health

Revenue (TTM) $2.3B
Revenue growth (YoY) -0.9%
Net margin 6.9%
Free cash flow −$28.4M FY2025
P/E ratio 10.3
Operating margin -12.4%
More key figures
EPS (TTM) $0.0400
EPS growth (YoY) -68.0%
Net debt $1.7B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 17, 2026. TTM = trailing twelve months.

About the company

Global Bio-chem Technology Group Company Limited, an investment holding company, manufactures and sells corn refined products and corn-based biochemical products in the People's Republic of China, Asia, the Americas, and internationally. It operates through four segments: Upstream Products, Amino Acids, Corn Sweeteners, and Polyol Chemicals. The company offers corn refined products, including corn oil, corn steep liquor, corn starch, waxy corn starch, corn gluten meals, feed pellets, and corn germ cakes. It also provides downstream corn based biochemical products, such as amino acids comprising lysine, protein lysine, threonine, and glutamic acid; corn sweeteners, which include high fructose corn syrup, maltodextrin, high maltose syrup, maltose syrup, sorbitol, glucose, and crystallized glucose; modified starches; and chemicals, such as ethylene, propylene, and butylene glycols, as well as resins. In addition, the company offers polyol chemicals, anti-freeze products, hydrogen, and …

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Global Bio-chem Technology Group reported revenue of $2.3B in FY2025 versus $747M in FY2021, a compound +32.1%/yr. Reported net income was $156M in FY2025.

Revenue +32.1%/yr
FY21 $747M
FY22 $12.7M
FY23 $1.4B
FY24 $2.0B
FY25 $2.3B
Net income
FY21 −$401M
FY22 −$1.4B
FY23 $4.2B
FY24 $770M
FY25 $156M

Is GBCMY fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Global Bio-chem Technology Group Fair Value". https://www.fairvalue-calculator.com/stock/GBCMY

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
Nestlé India Limited NESTLEIND ₹1,386 ₹278.10 -80%
Uni-President Enterprises Corp 1216 73.80 TWD 61.57 TWD -17%
Britannia Industries Limited BRITANNIA ₹5,218 ₹3,567 -32%
Tata Consumer Products Limited TATACONSUM ₹1,108 ₹328.05 -70%
PT Indofood CBP Sukses Makmur Tbk ICBP 6,600 IDR 14,500 IDR +120%
Samyang Foods Co 003230 1,000,000 KRW 1,066,643 KRW +7%
Vietnam Dairy Products Joint Stock Company VNM 60,798 VND 51,518 VND -15%
Patanjali Foods Limited PATANJALI ₹419.60 ₹156.15 -63%
PT Mayora Indah Tbk, MYOR 1,600 IDR 2,175 IDR +36%
PT Cisarua Mountain Dairy Tbk CMRY 4,120 IDR 4,821 IDR +17%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Global Bio-chem Technology Group (GBCMY) undervalued?
As of Jul 17, 2026, our model estimates a fair value of $1.77 versus a price of $4.14, about −57% (overvalued). Model-based estimate, not financial advice.
What is the fair value of GBCMY?
Our model-based fair value for Global Bio-chem Technology Group is $1.77 (as of Jul 17, 2026), built from audited fundamentals. The current price is $4.14.
What is the quality score of GBCMY?
Global Bio-chem Technology Group has a Quality Score of 42/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Global Bio-chem Technology Group (GBCMY)?
Global Bio-chem Technology Group reported trailing-twelve-month revenue of about $2.3B (latest available figure, as of Jul 17, 2026).
What is the net profit margin of GBCMY?
The net profit margin of Global Bio-chem Technology Group is about 6.9%, meaning it keeps roughly 6.9% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

Free alert · no account needed

Tell me when Global Bio-chem Technology Group reaches its Fair Value

Just your email, and we'll notify you when the price and Fair Value of Global Bio-chem Technology Group materially change. Free bonus: the monthly Top-25 report of the most undervalued quality stocks.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.